Substance Abuse
News Category

Wolfson Group Targets U.S. Retail Expansion at ECRM Event
Wolfson Group will attend the ECRM Vitamin, Weight Management & Sports Nutrition Session to meet with U.S. retailers and expand its wellness brands be...

New Bilingual Telehealth Clinic Launches to Address GLP-1 Access Gap for Latino Patients
Sol y Vida Clinic, a bilingual telehealth platform, launched nationwide to tackle the stark disparity in GLP-1 medication access for Hispanic patients...

FDA Inaction Allows Black Market for Unapproved Weight-Loss Drug to Flourish Online
The FDA's failure to aggressively combat the illegal online sale of retatrutide, an unapproved investigational drug, has led to a dangerous black mark...

Companies Rethink GLP-1 Drug Coverage as Costs and Questions Mount
As GLP-1 drug use surges, many U.S. companies are discontinuing coverage in employee health plans, prompting a deeper look into the reasons and implic...

School-Based Plyo-HIIT Program Aims to Improve Muscle-to-Fat Ratio in Children
A new randomized controlled trial tests whether a school-based plyometric and high-intensity interval training program can improve muscle-to-fat ratio...

Wolfson Group Highlights Shift Toward Informed Wellness in Weight Management
Wolfson Group discusses how evolving consumer trends are reshaping the weight management market, emphasizing transparency and multi-ingredient formula...

Illicit Retatrutide Sales Surge: What Consumers Need to Know
Retatrutide, an unapproved investigational drug, is being illegally sold online, leading to a 265% increase in poison control reports and hospitalizat...

New Precision Obesity Models Aim to Close Translational Gap in Anti-Obesity Drug Development
As next-generation obesity therapies emerge, traditional preclinical models fall short, prompting Protheragen Obesity to launch a tiered system of gen...

Nashville Concierge Medicines Releases New Educational Content on GLP-1 Treatment for Diabetes
Nashville Concierge Medicines announces new content for confidential patient care, focusing on GLP-1 medications to help manage diabetes, blood sugar ...
